Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
73°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
23Andme Holding Co.
(NQ:
ME
)
0.3234
+0.0131 (+4.22%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about 23Andme Holding Co.
< Previous
1
2
3
4
5
6
7
8
9
Next >
ME Stock Earnings: 23andMe Holding Beats EPS, Misses Revenue for Q1 2025
August 08, 2024
ME stock results show that 23andMe Holding beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025.
Via
InvestorPlace
23andMe Reports First Quarter Fiscal 2025 Financial Results
August 08, 2024
From
23andMe, Inc.
Via
GlobeNewswire
ME Stock Alert: CEO Anne Wojcicki Enters $200 Million Buyout Offer for 23andMe
August 02, 2024
23andMe stock is up on Friday as investors react to an offer from the company's founder to take it private for 40 cents per share for ME.
Via
InvestorPlace
23andMe Special Committee responds to CEO’s take-private proposal
August 02, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Looking Into 23andMe Holding's Recent Short Interest
June 12, 2024
Via
Benzinga
23andMe Announces CEO’s Take-Private Proposal
August 01, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe to Report Q1 FY2025 Financial Results
July 25, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research
July 25, 2024
Study aims to build a comprehensive, open-source database of heritable genetics and patient-reported data in lung cancer
From
23andMe, Inc.
Via
GlobeNewswire
The 3 Best Personalized Nutrition Stocks to Buy Now
July 24, 2024
Explore personalized nutrition stocks capitalizing on AI, machine learning and genetic profiling to provide targeted dietary solutions.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
23ANDME INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates 23andMe Holding Co. - ME
July 19, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
3 High-Dividend Stocks to Buy if You Are Seeking Consistent Payouts
July 11, 2024
Hercules Capital, Pfizer and Target offer stability, growth potential and reliable dividends in the realm of high-dividend stocks.
Via
InvestorPlace
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
June 28, 2024
From
23andMe, Inc.
Via
GlobeNewswire
3 Ultra-High-Yield Dividend Stocks to Buy Hand Over Fist Right This Instant
June 27, 2024
Business development companies can be a lucrative source of passive income.
Via
The Motley Fool
3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition
June 11, 2024
Don’t miss out on these three penny stocks, which have amazing potential to take off following upcoming business developments this year.
Via
InvestorPlace
23andMe Launches New Genetic Report on Bipolar Disorder
June 05, 2024
Provides 23andMe+ Premium members with insight into their likelihood of developing the serious mental health illness based on thousands of genetic variants
From
23andMe, Inc.
Via
GlobeNewswire
Why 23andMe Stock Tumbled 10% on Tuesday
June 04, 2024
Is altruism a good idea for an unprofitable capitalistic enterprise?
Via
The Motley Fool
23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community
June 04, 2024
Study aims to fill research gap and empower people through access to information about their health
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting
June 03, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history
May 29, 2024
Findings from 23andMe research on Parkinson’s disease published in Brain
From
23andMe, Inc.
Via
GlobeNewswire
ME Stock Earnings: 23andMe Holding Beats EPS, Beats Revenue for Q4 2024
May 23, 2024
ME stock results show that 23andMe Holding beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
May 23, 2024
Via
Benzinga
23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
May 23, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
May 14, 2024
Lemonaid Health will offer customers more affordable access to fast-acting branded ED medication that works as quickly as 15 minutes prior to sexual activity
From
23andMe, Inc.
Via
GlobeNewswire
23andMe to Report Q4 and Full Year FY2024 Financial Results
May 09, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Potter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach Case
April 30, 2024
From
Potter Handy LLP
Via
Business Wire
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
Data from neuroendocrine and ovarian cancer patient cohorts in the Phase 1/2a clinical trial of 23ME-00610 to be presented
From
23andMe, Inc.
Via
GlobeNewswire
This Technology Company Is Being Acquired at a Shocking 207% Premium -- and These 2 Stocks Could Be Next
April 23, 2024
Matterport is being acquired by a real estate giant, but it might not be the last ex-SPAC to go this route.
Via
The Motley Fool
Nasdaq Down 0.5%; Lithium Americas Shares Slide
April 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 18, 2024
Via
Benzinga
Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher
April 18, 2024
Via
Benzinga
Exposures
Fossil Fuels
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.